Skip to search formSkip to main contentSkip to account menu

Moxalactam:Susc:Pt:Isolate:OrdQn:MIC

Known as: Latamoxef:Sensibilité:Ponctuel:Isolat:Alphanumérique:CMI, Moxalactam:Susc:Pt:Isolado:OrdQn:Concentração inibitória mínima, Moxalactam:Sensibilidad:Punto temporal:Aislado:Ordinal Cuantitativo:Concentración mínima inhibitoria (CMI) 
National Institutes of Health

Related topics

Related topics

3 relations
Isolate - microorganismMinimum Inhibitory Concentration measurementMoxalactam

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Moxalactam and piperacillin: A study of in vitro characteristics and pharmacokinetics in cancer patients
SummaryWe evaluated the microbiologic characteristics including MIC determinations, synergy plate assays and serum bactericidal… 
2004
2004
Moxalactam penetration of normal and osteomyelitic bon
SummaryThe ability of moxalactam, a new cephalosporin, to cross the capillary membrane and enter the interstitial fluid space of… 
2002
2002
Noncovalent interaction energies in covalent complexes: TEM‐1 β‐lactamase and β‐lactams
The class A β‐lactamase TEM‐1 is a key bacterial resistance enzyme against β‐lactam antibiotics, but little is known about the… 
1983
1983
Moxalactam therapy of serious infections
SummaryTwenty-four patients were treated with moxalactam for 25 serious infections. Nineteen patients were septicemic and 18… 
1981
1981
Zur Frage der Penetration von Moxalactam in den Knochen
ZusammenfassungBei 8 Patienten mit einem Durchschnittsalter von 71,5 Jahren betrug nach 5 minütiger Injektion von 2 g Moxalactam… 
1980
1980
In-vitro-Eigenschaften von Moxalactam (LY 127935)
ZusammenfassungDie antibakterielle Aktivität von Moxalactam (LY 127935) wurde an 517 klinischen Isolaten im Vergleich zu… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)